N-3 polyunsaturated fatty acids may affect the course of COVID-19
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60460709%3A41210%2F22%3A91358" target="_blank" >RIV/60460709:41210/22:91358 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.957518/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fimmu.2022.957518/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fimmu.2022.957518" target="_blank" >10.3389/fimmu.2022.957518</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
N-3 polyunsaturated fatty acids may affect the course of COVID-19
Popis výsledku v původním jazyce
The highly infectious coronavirus disease (COVID 19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV 2), which is a new coronavirus that has been spreading since late 2019 and has caused millions of deaths worldwide. COVID 19 continues to spread rapidly worldwide despite high vaccination coverage therefore, it is crucial to focus on prevention. Most patients experience only mild symptoms of COVID 19. However, in some cases, serious complications can develop mainly due to an exaggerated immune response that is, a so called cytokine storm, which can lead to acute respiratory distress syndrome, organ failure, or, in the worst cases, death. N3 polyunsaturated fatty acids and their metabolites can modulate inflammatory responses, thus reducing the over release of cytokines. It has been hypothesized that supplementation of n3 polyunsaturated fatty acids could improve clinical outcomes in critically ill COVID 19 patients. Some clinical trials have shown that administering n3 polyuns
Název v anglickém jazyce
N-3 polyunsaturated fatty acids may affect the course of COVID-19
Popis výsledku anglicky
The highly infectious coronavirus disease (COVID 19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV 2), which is a new coronavirus that has been spreading since late 2019 and has caused millions of deaths worldwide. COVID 19 continues to spread rapidly worldwide despite high vaccination coverage therefore, it is crucial to focus on prevention. Most patients experience only mild symptoms of COVID 19. However, in some cases, serious complications can develop mainly due to an exaggerated immune response that is, a so called cytokine storm, which can lead to acute respiratory distress syndrome, organ failure, or, in the worst cases, death. N3 polyunsaturated fatty acids and their metabolites can modulate inflammatory responses, thus reducing the over release of cytokines. It has been hypothesized that supplementation of n3 polyunsaturated fatty acids could improve clinical outcomes in critically ill COVID 19 patients. Some clinical trials have shown that administering n3 polyuns
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30102 - Immunology
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2022
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Frontiers in Immunology
ISSN
1664-3224
e-ISSN
1664-3224
Svazek periodika
13
Číslo periodika v rámci svazku
Sep
Stát vydavatele periodika
CH - Švýcarská konfederace
Počet stran výsledku
12
Strana od-do
1-12
Kód UT WoS článku
000868652200001
EID výsledku v databázi Scopus
2-s2.0-85139549317